| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_LPAR1_0001000 | Exon-Exon | chr9:113635868-113636920 | chr9:110873588-110874640 | 1053 nt | 0.3352 |
| hsa_LPAR1_0002200 | Exon-Exon | chr9:113703701-113704448 | chr9:110941421-110942168 | 748 nt | 0.4840 |
| hsa_LPAR1_0002300 | Exon-Exon | chr9:113703701-113734500 | chr9:110941421-110972220 | 896 nt | 0.4855 |
| hsa_LPAR1_0002400 | Exon-Exon | chr9:113703701-113735838 | chr9:110941421-110973558 | 974 nt | 0.4867 |
| hsa_LPAR1_0002500 | Intron-Exon-Intron | chr9:113703701-113767819 | chr9:110941421-111005539 | 250 nt | 0.4360 |
| hsa_LPAR1_0002600 | Intron-Exon-Intron | chr9:113703701-113771481 | chr9:110941421-111009201 | 250 nt | 0.3120 |
| hsa_LPAR1_0002700 | Intron-Exon-Intron | chr9:113703701-113773970 | chr9:110941421-111011690 | 250 nt | 0.3560 |
| hsa_LPAR1_0002800 | Intron-Exon-Intron | chr9:113703701-113798481 | chr9:110941421-111036201 | 250 nt | 0.4160 |
| hsa_LPAR1_0003900 | Exon-Exon | chr9:113734353-113734500 | chr9:110972073-110972220 | 148 nt | 0.4932 |
| hsa_LPAR1_0004000 | Exon-Exon | chr9:113734353-113735838 | chr9:110972073-110973558 | 226 nt | 0.4956 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].